Hurwitz, S.J.; McBrearty, N.; Arzumanyan, A.; Bichenkov, E.; Tao, S.; Bassit, L.; Chen, Z.; Kohler, J.J.; Amblard, F.; Feitelson, M.A.;
et al. Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator. Viruses 2021, 13, 114.
https://doi.org/10.3390/v13010114
AMA Style
Hurwitz SJ, McBrearty N, Arzumanyan A, Bichenkov E, Tao S, Bassit L, Chen Z, Kohler JJ, Amblard F, Feitelson MA,
et al. Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator. Viruses. 2021; 13(1):114.
https://doi.org/10.3390/v13010114
Chicago/Turabian Style
Hurwitz, Selwyn J., Noreen McBrearty, Alla Arzumanyan, Eugene Bichenkov, Sijia Tao, Leda Bassit, Zhe Chen, James J. Kohler, Franck Amblard, Mark A. Feitelson,
and et al. 2021. "Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator" Viruses 13, no. 1: 114.
https://doi.org/10.3390/v13010114
APA Style
Hurwitz, S. J., McBrearty, N., Arzumanyan, A., Bichenkov, E., Tao, S., Bassit, L., Chen, Z., Kohler, J. J., Amblard, F., Feitelson, M. A., & Schinazi, R. F.
(2021). Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator. Viruses, 13(1), 114.
https://doi.org/10.3390/v13010114
